Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |